• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Watch: CND Life Sciences Wins Breakthrough Device Designation for Skin-Based Neurodegenerative Test

FDA Watch: CND Life Sciences Wins Breakthrough Device Designation for Skin-Based Neurodegenerative Test

by Ron Shinkman | Nov 26, 2025 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

The Syn-One assay can diagnose multiple conditions without needing a lumbar puncture

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Challenges and Advances in Sepsis Detection

Challenges and Advances in Sepsis Detection

by Zahraa Chorghay, PhD | Oct 31, 2025 | Clinical Diagnostics Insider, Testing Trends-dtet

FDA-approved tests like Intellisep and TriVerity demonstrate potential for early sepsis diagnosis

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Debate—Resolved: Immunohistochemistry Should Be Regulated As An Assay

A Debate—Resolved: Immunohistochemistry Should Be Regulated As An Assay

by G2 Intelligence Staff | Mar 18, 2024 | OLP-Regular, Webinars, webinars free

Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes

Don’t Sell Your Lab, Grow Your Lab

Don’t Sell Your Lab, Grow Your Lab

by G2 Intelligence Staff | Feb 21, 2024 | OLP-Regular, Webinars, webinars free

Join us and our experts to learn how labs can reimagine infrastructure utilization through collaboration to improve health system finances and enrich their value proposition

Diagnostic Error: What Harm Can It Do?

Diagnostic Error: What Harm Can It Do?

by Michael Schubert, PhD | Aug 29, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet

Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com